Robert A. Brodsky,Richard J. Jones,Richard F. Ambinder
申请号：
US13232326
公开号：
US20120100162A1
申请日:
2011.09.14
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to methods of treating a cancer and in particular, a B-cell derived cancer, using a lymphocytotoxic but hematopoeitic cell sparing high-dose pulsed amount of an oxazaphosphorine drug, either alone, or in combination with immune therapeutics such as, for example, monoclonal antibodies that selectively bind B-cell specific antigens.
